Date published: 2026-5-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

AS 1949490 (CAS 1203680-76-5)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
3-[(4-Chlorophenyl)methoxy]-N-[(1S) -1-phenylethyl]thiophene-2-carboxamide
Application:
AS 1949490 is a selective SHIP2 (SH2 domain-containing inositol 5′ phosphatase 2) inhibitor
CAS Number:
1203680-76-5
Purity:
≥99% Chemical, ≥99% Enantiomeric
Molecular Weight:
371.88
Molecular Formula:
C20H18ClNO2S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Available in US only.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

AS 1949490 is a small-molecule inhibitor with specificity for the p70 ribosomal S6 kinase (p70S6K), an important kinase in the mTOR (mammalian target of rapamycin) signaling pathway. As a potent and selective inhibitor, it provides valuable insights into the mechanisms regulating protein synthesis and cell growth. By specifically inhibiting p70S6K, AS 1949490 allows researchers to investigate the downstream effects of p70S6K inhibition on cell proliferation, protein synthesis, and metabolic regulation. In various studies, the compound has been used to explain the role of p70S6K in cancer cell growth, as mTOR signaling often becomes dysregulated in cancer cells. Additionally, it has been employed in cell culture systems to determine the impact of S6 phosphorylation on translational control. AS 1949490 aids in understanding how p70S6K activity affects key cellular processes, like autophagy, glucose metabolism, and lipid biosynthesis. Beyond cancer research, AS 1949490′s specific inhibition of p70S6K also helps explore neurobiology, as p70S6K is involved in synaptic plasticity and cognitive functions. This chemical′s ability to modulate mTOR signaling makes it an invaluable tool for deciphering the complex regulation of cellular growth, protein translation, and metabolic pathways, contributing significantly to current molecular biology and biochemistry research.


AS 1949490 (CAS 1203680-76-5) References

  1. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.  |  Suwa, A., et al. 2009. Br J Pharmacol. 158: 879-87. PMID: 19694723
  2. Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubes.  |  Suwa, A., et al. 2010. Eur J Pharmacol. 642: 177-82. PMID: 20558154
  3. Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch.  |  Kleyer, J., et al. 2012. Biochem Pharmacol. 83: 1393-412. PMID: 22387618
  4. Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid.  |  Chang, P., et al. 2014. Neurobiol Dis. 62: 296-306. PMID: 24148856
  5. Screening assay for small-molecule inhibitors of synaptojanin 1, a synaptic phosphoinositide phosphatase.  |  McIntire, LB., et al. 2014. J Biomol Screen. 19: 585-94. PMID: 24186361
  6. AS1949490, an inhibitor of 5'-lipid phosphatase SHIP2, promotes protein kinase C-dependent stabilization of brain-derived neurotrophic factor mRNA in cultured cortical neurons.  |  Tsuneki, H., et al. 2019. Eur J Pharmacol. 851: 69-79. PMID: 30753865
  7. Novel pharmacological actions of trequinsin hydrochloride improve human sperm cell motility and function.  |  McBrinn, RC., et al. 2019. Br J Pharmacol. 176: 4521-4536. PMID: 31368510
  8. Scaffold dependent role of the inositol 5'-phosphatase SHIP2, in regulation of oxidative stress induced apoptosis.  |  Azzi, A. 2021. Arch Biochem Biophys. 697: 108667. PMID: 33181128
  9. Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention.  |  Whitfield, H., et al. 2021. J Med Chem. 64: 3813-3826. PMID: 33724834
  10. Cell Culture Media, Unlike the Presence of Insulin, Affect α-Synuclein Aggregation in Dopaminergic Neurons.  |  Hlushchuk, I., et al. 2022. Biomolecules. 12: PMID: 35454152
  11. Beyond PPARs and metformin: new insulin sensitizers for the treatment of type 2 diabetes  |  Carpino, P. A., & Hepworth, D. 2012. Annual Reports in Medicinal Chemistry. 47: 177-192.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

AS 1949490, 10 mg

sc-358828
10 mg
$240.00
US: Only available in the US

AS 1949490, 50 mg

sc-358828A
50 mg
$1110.00
US: Only available in the US